Certain Antibiotic Might Combat Children’s Wheezing Episodes
Kids given azithromycin were less likely to develop severe respiratory illness, study says (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - November 17, 2015 Category: Respiratory Medicine Authors: webmaster at doctorslounge.com Tags: Family Medicine, Infections, Nursing, Pediatrics, Pharmacy, Pulmonology, Asthma, News, Source Type: news

Answers elusive in quest for better chlamydia treatment
SAN DIEGO – The hottest topic today in the treatment of sexually transmitted diseases caused by Chlamydia trachomatis is the unresolved question of whether azithromycin is still as effective as doxycycline, the other current guideline-recommended, first-line therapy, Dr. Kimberly Workowski... (Source: Skin and Allergy News)
Source: Skin and Allergy News - November 7, 2015 Category: Dermatology Source Type: news

Two commonly used antibiotics OK during pregnancy
Stephen FellerMONTREAL, Oct. 30 (UPI) -- Researchers found that two of the most commonly used antibiotics -- azithromycin and clarithromycin -- are safe for women to take during pregnancy. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 30, 2015 Category: Consumer Health News Source Type: news

Study Sees No Link Between Antibiotics in Early Pregnancy and Birth Defects
Researchers looked for risk among women prescribed drugs that include azithromycin (Source: WebMD Health)
Source: WebMD Health - October 30, 2015 Category: Consumer Health News Source Type: news

ACOG Advocates Dual Therapy for Gonococcal InfectionsACOG Advocates Dual Therapy for Gonococcal Infections
Ceftriaxone plus azithromycin is the recommended first-line regimen in the face of antimicrobial resistance. Medscape Medical News (Source: Medscape PublicHealth Headlines)
Source: Medscape PublicHealth Headlines - October 22, 2015 Category: Primary Care Tags: Ob/Gyn & Women ' s Health News Source Type: news

Azithromycin noninferior to doxycycline for chlamydia
BRISBANE, AUSTRALIA – Azithromycin has been shown to be noninferior to doxycycline in the treatment of chlamydia, in a randomized clinical trial conducted in a youth correctional facility. The study, presented at the World STI & HIV Congress 2015, found a 7-day, twice-daily regimen of 100 mg... (Source: Skin and Allergy News)
Source: Skin and Allergy News - September 15, 2015 Category: Dermatology Source Type: news

Viewpoint: Azithromycin: Always the Wrong Respiratory Drug
No abstract available (Source: Emergency Medicine News)
Source: Emergency Medicine News - August 1, 2015 Category: Emergency Medicine Tags: Viewpoint Source Type: news

Study: Common antibiotic kills drug-resistant bacteria
Stephen FellerSAN DIEGO, June 10 (UPI) -- The common antibiotic azithromycin, sold as Zithromax Z-Pak, was found to kill multidrug-resistant bacteria in lab tests more closely mimicking the human body. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 10, 2015 Category: Consumer Health News Source Type: news

Common antibiotic may be the answer to many multidrug-resistant bacterial infections
The common antibiotic azithromycin kills many multidrug-resistant bacteria very effectively — when tested under conditions that closely resemble the human body and its natural antimicrobial factors. The researchers believe the finding could prompt an immediate review of the current standard of care for patients with certain so-called “superbug” infections. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 10, 2015 Category: Science Source Type: news

Common antibiotic may be the answer to many multidrug-resistant bacterial infections
(University of California - San Diego) Researchers at University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences report that the common antibiotic azithromycin kills many multidrug-resistant bacteria very effectively -- when tested under conditions that closely resemble the human body and its natural antimicrobial factors. The researchers believe the finding, published June 10 by EBioMedicine, could prompt an immediate review of the current standard of care for patients with certain so-called 'superbug' infections. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 10, 2015 Category: Infectious Diseases Source Type: news

CDC Issues Advisory About Multi-Drug Resistant Shigellosis (FREE)
By Amy Orciari Herman Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH The CDC is increasingly seeing shigellosis that's resistant to ciprofloxacin or azithromycin, as well as other antimicrobials, the agency warned in a health alert … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - June 8, 2015 Category: Primary Care Source Type: news

Growing Concern Over Drug-Resistant Shigella in USGrowing Concern Over Drug-Resistant Shigella in US
Recent outbreaks of Shigellosis in the United States that are resistant to ciprofloxacin, azithromycin, and other antibiotics prompts a Health Alert Network advisory from federal health officials. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 6, 2015 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Notes from the Field: Outbreaks of Shigella sonnei Infection with Decreased Susceptibility to Azithromycin Among Men Who Have Sex with Men — Chicago and Metropolitan Minneapolis-St. Paul, 2014
(Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - June 5, 2015 Category: American Health Source Type: news

Azithromycin Unlikely to Be Effective for Shigellosis in Men Who Have Sex With Men (FREE)
By Cara Adler Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS All tested Shigella isolates from two recent outbreaks among men who have sex with men showed … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - June 5, 2015 Category: Primary Care Source Type: news

Azithromycin vs Doxycycline in Meibomian Gland DysfunctionAzithromycin vs Doxycycline in Meibomian Gland Dysfunction
In a new head-to-head comparison of the two antibiotics for meibomian gland dysfunction, azithromycin showed to be the overall better treatment choice. The British Journal of Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 27, 2015 Category: Consumer Health News Tags: Ophthalmology Journal Article Source Type: news